Olanzapine treatment in an organic hallucinosis patient.

نویسندگان

  • Roberto Umansky
  • Vadim Geller
چکیده

A.L., a 42-yr-old man has been in treatment at our out- patient clinic since 1992 suffering from psychotic manifestations following a second severe closed-head injury. The patient had his first contact with a psychiatrist 3 yr after his first severe head injury in 1962 (when 10 yr old). During his first hospitalization (in 1994) he presented with signs of affective flattening and behavioural problems and indications of borderline intellectual functioning or mild mental retardation. The patient underwent several surgical interventions. The early inter-operative period was complicated by behavioural problems and a lack of motivation. At that time his intellectual tests (WAIS) showed a decline of results to a level of 60-80 in verbal tests, with a significant decrease in performance results. However, after further surgery, his intellectual condition improved enabling him to complete a secondary-school education, get married and start work as an industrial worker. From that time onwards he had no contact with psychiatrists, nor did he receive any medication treatment.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note.

BACKGROUND Hallucinosis is a dopaminergic dose limiting complication of the treatment of idiopathic Parkinson's disease. Typical neuroleptic medications cannot be used for suppressing hallucinosis because the extrapyramidal side effects worsen parkinsonian motor control. Olanzapine is a novel atypical antipsychotic drug with few reported extrapyramidal side effects which may be more suitable fo...

متن کامل

A potential case of peduncular hallucinosis treated successfully with olanzapine.

Visual hallucinations have a differential diagnosis, both psychiatric and nonpsychiatric in nature. Described first by Lhermitte, peduncular hallucinosis is an uncommon etiology of visual hallucinations (VH). Typically, the offending lesion is vascular in origin and occurs at the level of the midbrain, thalamus, or rostral brainstem. Interestingly, the origin of the VH in our patient's case cou...

متن کامل

Olanzapine-Induced Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics. Although NMS is less common with atypical antipsychotic, but it seems that its incidence is rising due to increased administration of such drug...

متن کامل

First Episode of Psychosis in a Middle-Aged Patient with a 14-Year History of Conversion Disorder

We present a case of a middle-aged male patient with a long history of conversion disorder and histrionic personality, who presented with newly onset psychotic symptoms while being engaged to treatment with a community mental health team in a primary care setting. The symptoms could not be attributed to an organic cause. After a short course of olanzapine treatment which caused adverse effects,...

متن کامل

Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study.

AIMS The aim of this study was to compare the efficacy and safety of valproate (Depakine-Chrono) versus placebo for the treatment of acute alcohol hallucinosis. METHODS 10 days' randomized, double-blind, parallel study was conducted; 40 patients with an ICD-10 diagnosis of acute alcohol hallucinosis were randomized to valproate (Depakine-Chrono) 3000 mg/day (n = 20) or placebo (n = 20). The p...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The international journal of neuropsychopharmacology

دوره 3 1  شماره 

صفحات  -

تاریخ انتشار 2000